Smac-mimetic IAP-antagonists sensitize TRAIL-induced apoptosis by blocking XIAP function in multiple tumor models, including breast cancer [32], multiple myeloma [16], glioblastoma [11] and ovarian cancer [33]. Here, XIAP is linked to ovarian carcinoma.